Related Experiment Videos
Induction of differentiation in Friend-erythroleukemia cells by aclacinomycin A: early transient decrease in c-myc
A Schaefer1, A Dressel, K Lingelbach
1Department of Toxicology, University of Hamburg Medical School, Germany.
Leukemia
|August 1, 1992
Summary
Aclacinomycin A, an antitumor drug, transiently decreases c-myc and c-myb mRNA in Friend erythroleukemia cells, indicating an early differentiation effect. This early biochemical change precedes irreversible terminal differentiation.
Area of Science:
- Molecular Biology
- Cancer Research
- Cell Differentiation
Background:
- Chemical inducers of differentiation typically cause a transient decrease in c-myc and c-myb mRNA levels in Friend erythroleukemia cells.
- This early event precedes the down-regulation of c-myc and c-myb expression during irreversible terminal differentiation.
Purpose of the Study:
- To investigate the early effect of aclacinomycin A, a potent differentiation-inducing anthracycline antitumor antibiotic, on c-myc and c-myb mRNA levels.
- To determine if the observed decrease in mRNA levels is specific to differentiation induction.
Main Methods:
- Utilized Northern blot analysis to examine c-myc and c-myb mRNA levels in the Friend cell line (F4-6).
- Compared the effects of aclacinomycin A with dimethylsulfoxide and actinomycin D.
- Assessed the impact of adriamycin, an anthracycline that reduces proliferation without inducing differentiation.
Main Results:
- Aclacinomycin A rapidly decreased c-myc and c-myb transcript levels within 0.5-1 hour and 2-3 hours, respectively.
- The time course of this decline mirrored that seen with dimethylsulfoxide or actinomycin D.
- c-myc and c-myb mRNA levels returned to pretreatment levels by 12-18 hours post-treatment.
- Adriamycin did not induce a similar early decrease in c-myc and c-myb expression.
Conclusions:
- The transient decrease in c-myc and c-myb mRNA levels induced by aclacinomycin A is likely an early biochemical marker of differentiation.
- This effect appears specific to differentiation-inducing agents, as adriamycin did not elicit the same response.